{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T19:35:21Z","timestamp":1793216121013,"version":"4.5.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Advances"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jacadv.2026.103243","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T19:17:31Z","timestamp":1789759051000},"page":"103243","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P2","title":["Sex Differences in Coronary Atheroma Regression After Intensive Lipid-Lowering Therapy"],"prefix":"10.1016","volume":"5","author":[{"given":"Agam","family":"Bansal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"St. John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rishi","family":"Puri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Nicholls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7231-6464","authenticated-orcid":false,"given":"Steven E.","family":"Nissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.jacadv.2026.103243_bib1","doi-asserted-by":"crossref","first-page":"e254","DOI":"10.1161\/CIR.0000000000000950","article-title":"Heart disease and stroke statistics\u20142021 update: a report from the American Heart Association","volume":"143","author":"Virani","year":"2021","journal-title":"Circulation"},{"issue":"15","key":"10.1016\/j.jacadv.2026.103243_bib2","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJMoa040583","article-title":"Intensive versus moderate lipid lowering with statin after acute coronary syndromes","volume":"350","author":"Cannon","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacadv.2026.103243_bib3","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1001\/jamacardio.2023.2731","article-title":"Atherosclerotic coronary plaque regression and risk of adverse cardiovascular events: a systematic review and updated meta-regression analysis","volume":"8","author":"Iatan","year":"2023","journal-title":"JAMA Cardiol"},{"issue":"9","key":"10.1016\/j.jacadv.2026.103243_bib4","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1001\/jama.291.9.1071","article-title":"Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial (REVERSAL)","volume":"291","author":"Nissen","year":"2004","journal-title":"JAMA"},{"issue":"13","key":"10.1016\/j.jacadv.2026.103243_bib5","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1001\/jama.295.13.jpc60002","article-title":"Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial","volume":"295","author":"Nissen","year":"2006","journal-title":"JAMA"},{"issue":"22","key":"10.1016\/j.jacadv.2026.103243_bib6","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1056\/NEJMoa1110874","article-title":"Effect of two intensive statin regimens on progression of coronary disease: the SATURN trial","volume":"365","author":"Nicholls","year":"2011","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.jacadv.2026.103243_bib7","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1001\/jama.2016.16951","article-title":"Effect of evolocumab on progression of coronary disease in statin-treated patients: the GLAGOV randomized clinical trial","volume":"316","author":"Nicholls","year":"2016","journal-title":"JAMA"},{"issue":"18","key":"10.1016\/j.jacadv.2026.103243_bib8","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1001\/jama.2022.5218","article-title":"Effect of alirocumab on coronary atherosclerosis in patients with acute myocardial infarction (PACMAN-AMI)","volume":"327","author":"R\u00e4ber","year":"2022","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.jacadv.2026.103243_bib9","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"issue":"24","key":"10.1016\/j.jacadv.2026.103243_bib10","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1016\/j.jacc.2018.11.003","article-title":"2018 AHA\/ACC guideline on the management of blood cholesterol","volume":"73","author":"Grundy","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacadv.2026.103243_bib11","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1161\/CIRCULATIONAHA.122.062049","article-title":"Sex differences in 10-Year outcomes after percutaneous coronary intervention with drug-eluting stents: insights from the DECADE cooperation","volume":"147","author":"Coughlan","year":"2023","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.jacadv.2026.103243_bib12","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.1047","article-title":"Assessment of sex disparities in nonacceptance of statin therapy and low-density lipoprotein cholesterol levels among patients at high cardiovascular risk","volume":"6","author":"Brown","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"5","key":"10.1016\/j.jacadv.2026.103243_bib13","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.004264","article-title":"Race-sex differences in statin use and low-density lipoprotein cholesterol control among people with diabetes mellitus in the REGARDS study","volume":"6","author":"Gamboa","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"10","key":"10.1016\/j.jacadv.2026.103243_bib14","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.jcmg.2014.04.019","article-title":"Sex-related differences of coronary atherosclerosis regression following maximally intensive statin therapy: insights from SATURN","volume":"7","author":"Puri","year":"2014","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jacadv.2026.103243_bib15","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.atherosclerosis.2016.09.059","article-title":"Coronary atheroma progression rates in men and women following high-intensity statin therapy: pooled analysis from REVERSAL, ASTEROID and SATURN","volume":"254","author":"Stegman","year":"2016","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.jacadv.2026.103243_bib16","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jacc.2021.10.035","article-title":"Coronary atherosclerotic plaque regression: JACC state-of-the-art review","volume":"79","author":"Dawson","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"40","key":"10.1016\/j.jacadv.2026.103243_bib17","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1093\/eurheartj\/ehaa652","article-title":"Effect of icosapent ethyl on progression of coronary atherosclerosis (EVAPORATE trial)","volume":"41","author":"Budoff","year":"2020","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.jacadv.2026.103243_bib18","first-page":"409","article-title":"Lipid disorders in women: differences and implications for therapy","volume":"118","author":"Howard","year":"2022","journal-title":"Cardiovasc Res"},{"issue":"3","key":"10.1016\/j.jacadv.2026.103243_bib19","doi-asserted-by":"crossref","first-page":"320","DOI":"10.4244\/EIJ-D-16-00361","article-title":"Sex differences in plaque characteristics by intravascular imaging in patients with coronary artery disease","volume":"13","author":"ten Haaf","year":"2017","journal-title":"EuroIntervention"},{"issue":"1","key":"10.1016\/j.jacadv.2026.103243_bib20","doi-asserted-by":"crossref","first-page":"7999","DOI":"10.1038\/s41598-021-87528-w","article-title":"The effects of lipid-lowering therapy on coronary plaque regression: a systematic review and meta-analysis","volume":"11","author":"Li","year":"2021","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.jacadv.2026.103243_bib21","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1001\/jamacardio.2025.5520","article-title":"Prognostic value of plaque volume in patients with first diagnosis of coronary artery disease: a substudy of the PROMISE randomized clinical trial","volume":"11","author":"Kar\u00e1dy","year":"2026","journal-title":"JAMA Cardiol"},{"issue":"3","key":"10.1016\/j.jacadv.2026.103243_bib22","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jacc.2018.10.066","article-title":"Coronary artery plaque characteristics associated with adverse outcomes in the SCOT-HEART study","volume":"73","author":"Williams","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.jacadv.2026.103243_bib23","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrcardio.2015.124","article-title":"Dysfunctional HDL and atherosclerotic cardiovascular disease","volume":"13","author":"Rosenson","year":"2016","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jacadv.2026.103243_bib24","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jacl.2022.11.009","article-title":"Sex-related differences in premature cardiovascular disease in familial hypercholesterolemia","volume":"17","author":"Agarwala","year":"2023","journal-title":"J Clin Lipidol"},{"issue":"21","key":"10.1016\/j.jacadv.2026.103243_bib25","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1056\/NEJMoa0706628","article-title":"Effects of torcetrapib in patients at high risk for coronary events (ILLUMINATE)","volume":"357","author":"Barter","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacadv.2026.103243_bib26","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/GME.0b013e31803c764d","article-title":"Estrogen effects on arteries vary with stage of reproductive life and extent of subclinical atherosclerosis progression","author":"Clarkson","year":"2007","journal-title":"Menopause"},{"key":"10.1016\/j.jacadv.2026.103243_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2023.117275","article-title":"Sex differences in diagnostic modalities of atherosclerosis in the macrocirculation","volume":"384","author":"Kerkhof","year":"2023","journal-title":"Atherosclerosis"},{"issue":"8","key":"10.1016\/j.jacadv.2026.103243_bib28","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nrcardio.2012.64","article-title":"The importance of the endothelium in atherothrombosis and coronary artery disease","volume":"9","author":"Otsuka","year":"2012","journal-title":"Nat Rev Cardiol"},{"issue":"5","key":"10.1016\/j.jacadv.2026.103243_bib29","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.119.008869","article-title":"Healthy strut coverage after coronary stent implantation: an Ex vivo human autopsy study","volume":"13","author":"Jinnouchi","year":"2020","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jacadv.2026.103243_bib30","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1016\/j.jcin.2022.08.013","article-title":"Sex-related differences in thrombus burden in STEMI patients undergoing primary percutaneous coronary intervention","volume":"15","author":"Manzi","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"issue":"12","key":"10.1016\/j.jacadv.2026.103243_bib31","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Anti-inflammatory therapy with canakinumab for atherosclerotic disease (CANTOS trial)","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.jacadv.2026.103243_bib32","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1161\/CIRCRESAHA.114.302699","article-title":"Inflammation and its resolution as determinants of acute coronary syndromes","volume":"114","author":"Libby","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.jacadv.2026.103243_bib33","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.jcmg.2011.03.013","article-title":"NIRS and IVUS for characterization of atherosclerosis in patients undergoing coronary angiography","volume":"4","author":"Brugaletta","year":"2011","journal-title":"JACC Cardiovasc Imaging"},{"issue":"18","key":"10.1016\/j.jacadv.2026.103243_bib34","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease (FOURIER)","volume":"376","author":"Sabatine","year":"2017","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.jacadv.2026.103243_bib35","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","article-title":"Alirocumab and cardiovascular outcomes after acute coronary syndrome (ODYSSEY outcomes)","volume":"379","author":"Schwartz","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacadv.2026.103243_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.789931","article-title":"Emerging non-statin treatment options for lowering low-density lipoprotein cholesterol","volume":"8","author":"Bardolia","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jacadv.2026.103243_bib37","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.jacl.2017.05.001","article-title":"Update on the use of PCSK9 inhibitors in adults: recommendations from an expert panel of the National Lipid Association","volume":"11","author":"Orringer","year":"2017","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacadv.2026.103243_bib38","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1016\/j.jacc.2006.10.079","article-title":"Long-term prognosis associated with coronary calcification: observations from a registry of 25,253 patients","volume":"49","author":"Budoff","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"13","key":"10.1016\/j.jacadv.2026.103243_bib39","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1056\/NEJMoa070635","article-title":"Effect of torcetrapib on progression of coronary atherosclerosis","volume":"356","author":"Nissen","year":"2007","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jacadv.2026.103243_bib40","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jacc.2013.03.058","article-title":"Changes in plaque lipid content after intensive versus standard statin therapy: the YELLOW trial","volume":"62","author":"Kini","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"19","key":"10.1016\/j.jacadv.2026.103243_bib41","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1161\/CIRCULATIONAHA.110.968792","article-title":"Sex\/gender differences in cardiovascular disease prevention","volume":"124","author":"Mosca","year":"2011","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.jacadv.2026.103243_bib42","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/embor.2012.87","article-title":"Sex and gender differences in health: science & society series on sex and science","volume":"13","author":"Regitz-Zagrosek","year":"2012","journal-title":"EMBO Rep"},{"issue":"Suppl V","key":"10.1016\/j.jacadv.2026.103243_bib43","first-page":"V50","article-title":"Clinical relevance and application of optical coherence tomography","volume":"11","author":"Prati","year":"2015","journal-title":"EuroIntervention"},{"issue":"3","key":"10.1016\/j.jacadv.2026.103243_bib44","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1056\/NEJMoa1002358","article-title":"A prospective natural-history study of coronary atherosclerosis","volume":"364","author":"Stone","year":"2011","journal-title":"N Engl J Med"}],"container-title":["JACC: Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X26006642?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X26006642?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T19:24:35Z","timestamp":1793215475000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772963X26006642"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":44,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2772963X26006642"],"URL":"https:\/\/doi.org\/10.1016\/j.jacadv.2026.103243","relation":{},"ISSN":["2772-963X"],"issn-type":[{"value":"2772-963X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sex Differences in Coronary Atheroma Regression After Intensive Lipid-Lowering Therapy","name":"articletitle","label":"Article Title"},{"value":"JACC: Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacadv.2026.103243","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}],"article-number":"103243"}}